Strides Pharma Science Limited — Important, 19-03-2025: General Updates

Strides Pharma Science Limited has announced a board meeting regarding the successful closure of its acquisition of a 100% stake in Amexel Pte. Ltd., Singapore, by Strides Pharma Global Pte. Limited, a wholly owned subsidiary. With Amexel now under its umbrella, the company enhances its operational portfolio and expands its market presence. This strategic move could open up new revenue streams and strengthen shareholder confidence. Overall, this development may be viewed positively by investors, as it aligns with Strides' growth objectives and market expansion strategy.